LEWISVILLE, Texas / Oct 15, 2025 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that Massimo Calafiore, President and Chief Executive Officer, and Julie Andrews, Chief Financial Officer, will participate in the following investor conferences: UBS Global Healthcare Conference in Palm Beach Gardens, FL, November 11, 2025, at 1:15 pm Eastern Time Stifel... Read More

Company to Host Conference Call on Tuesday, November 4, 2025, at 8:30 am Eastern Time LEWISVILLE, Texas / Oct 14, 2025 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its third quarter 2025 financial results on Tuesday, November 4, 2025, before market open. The Company will host a conference call and webcast to review results at 8:30 am... Read More

LEWISVILLE, Texas / Aug 05, 2025 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2025, and reaffirmed its full-year 2025 financial guidance. All pro forma measures contained within this release exclude the impact of the Company’s decision to discontinue its M6® product lines. Highlights Second... Read More

Wednesday, August 13, 2025 at 9:00 am Eastern Time LEWISVILLE, Texas / Jul 16, 2025 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate at the Canaccord Genuity 45th Annual Growth Conference in Boston. Management is scheduled to present on Wednesday, August 13, 2025 at 9:00 am Eastern Time. Interested parties can access the... Read More

Company to Host Conference Call on Tuesday, August 5, 2025 at 8:30 am Eastern Time LEWISVILLE, Texas / Jul 15, 2025 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025 before market open. The Company will host a conference call and webcast to review results at 8:30 am... Read More

LEWISVILLE, Texas / Jun 17, 2025 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced the global commercial launch of the TrueLok™ Elevate Transverse Bone Transport (TBT) System. TrueLok Elevate represents the first commercially available device in the U.S. with a patented design for use in the TBT procedure to provide a limb preservation treatment option for... Read More

LEWISVILLE, Texas / May 06, 2025 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 2025, updated its full-year 2025 net sales guidance, and reaffirmed its full-year 2025 non-GAAP adjusted EBITDA and positive free cash flow guidance. All pro forma measures contained within this release exclude the... Read More

Company to Host Conference Call on Tuesday, May 6, 2025 at 8:30 am Eastern Time LEWISVILLE, Texas / Apr 15, 2025 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its first quarter 2025 financial results on Tuesday, May 6, 2025 before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern... Read More

LEWISVILLE, Texas / Mar 19, 2025 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and the European CE Mark for the TrueLok ™ Elevate Transverse Bone Transport (TBT) System. TrueLok... Read More

LEWISVILLE, Texas / Mar 12, 2025 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced the appointment of Vickie Capps to the Company's Board of Directors, effective March 11, 2025. “Vickie brings a wealth of experience to our Board at a pivotal stage for... Read More

Monday, March 17, 2025 at 8:00 am Pacific Time LEWISVILLE, Texas / Mar 03, 2025 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the 37th Annual Roth Conference in Dana Point, CA. Management is scheduled to present on Monday, March 17, 2025 at 8:00 am PT. Interested parties can access the live and archived webcast of the... Read More

Record Results Reflect Strong Execution as Company Focuses on Most Profitable Growth Opportunities in Spine, Orthopedics and Bone Growth Therapies LEWISVILLE, Texas / Feb 25, 2025 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the fourth quarter and full-year ended December 31, 2024, and provided full-year 2025 financial guidance.... Read More

Monday, March 10, 2025 at 9:00 am Pacific Time LEWISVILLE, Texas / Feb 17, 2025 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 9:00 am PT. Interested parties can access the live and... Read More

Company to Host Conference Call on Tuesday, February 25, 2025 at 8:30 am ET LEWISVILLE, Texas / Jan 28, 2025 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday, February 25, 2025 before market open. The Company will host a conference call and webcast to review results at... Read More

LEWISVILLE, Texas / Nov 12, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that Massimo Calafiore, President and Chief Executive Officer, and Julie Andrews, Chief Financial Officer, will participate in the following investor conferences: Stifel 2024 Healthcare Conference in New York, NY, November 18, 2024, fireside chat at 8:35 AM Eastern Time Stifel... Read More

Building on Positive Momentum from Compelling Combination of Profitable, Above-Market Growth with a Stronger Financial Profile LEWISVILLE, Texas / Nov 07, 2024 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the third quarter ended September 30, 2024, reiterated its full-year 2024 financial guidance, and introduced new three-year... Read More

New Financing Replaces Existing Term Loan and Seeks to Further Optimize the Company’s Capital Structure to Support Long-Term, Profitable Growth LEWISVILLE, Texas / Nov 07, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced the entry into a new credit agreement providing the Company with up to $275 million in a senior-secured term loan with a 48-month... Read More

Monday, November 18, 2024 at 8:35 am Eastern Time LEWISVILLE, Texas / Oct 21, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the Stifel 2024 Healthcare Conference in New York. Management is scheduled to present on Monday, November 18, 2024 at 8:35 am ET. Interested parties can access the live and archived webcast... Read More

Company to Host Conference Call on Thursday, November 7, 2024 at 8:30 am ET LEWISVILLE, Texas / Oct 10, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its third quarter 2024 financial results on Thursday, November 7, 2024 before market open. The Company will host a conference call and webcast to review results at 8:30 am ET the... Read More

LEWISVILLE, Texas / Sep 23, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global medical technology company, today announced the presentation of new data supporting the use of Orthofix’s proprietary Pulsed Electromagnetic Field (PEMF) stimulation to increase fusion rates as an adjunct to lumbar spine fusion surgery. Patients treated with the SpinalStim ™ bone growth therapy device demonstrated a high... Read More

LEWISVILLE, Texas / Aug 15, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Patrick Fisher as President of the Orthofix Global Orthopedics business. In this role, Fisher will serve on the company’s Executive Leadership team,... Read More

LEWISVILLE, Texas / Aug 06, 2024 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the second quarter ended June 30, 2024 and increased its full-year 2024 financial guidance. Recent Highlights Second quarter 2024 net sales of $198.6 million, an increase of 6% on a reported and constant currency basis compared to second quarter 2023 Bone Growth Therapies (BGT) net sales growth of... Read More

Wednesday, August 14, 2024 at 2:30 pm Eastern Time LEWISVILLE, Texas / Jul 17, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the Company will participate in Canaccord Genuity's 44th Annual Growth Conference in Boston. Management is scheduled to present on Wednesday, August 14, 2024 at 2:30 pm ET. Interested parties can access the live and... Read More

LEWISVILLE, Texas / Jul 16, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Stephanie Walsh as Chief Human Resources Officer. A seasoned human resources executive, Walsh joins Orthofix from ResMed Inc., a San Diego-based medical... Read More

Company to Host Conference Call on Tuesday, August 6, 2024 at 8:30 am ET LEWISVILLE, Texas / Jul 09, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its second quarter 2024 financial results on Tuesday, August 6, 2024 before market open. The Company will host a conference call and webcast to review results at 8:30 am ET the same... Read More

LEWISVILLE, Texas / Jul 09, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the 510(k) clearance and first U.S. implant of the Fitbone ™ Transport and Lengthening System. Used to treat large bone defects in the femur and tibia due to trauma,... Read More

LEWISVILLE, Texas / Jun 24, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Michael Finegan as Chair of the Board of Directors. Finegan was appointed to the Orthofix Board in December 2023. He is CEO at Acera Surgical, a bioscience... Read More

LEWISVILLE, Texas / Jun 18, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Aviva McPherron as President of Global Operations and Quality. As a member of the Executive Leadership Team, McPherron will oversee strategy for the... Read More

LEWISVILLE, Texas / Jun 11, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Julie Dewey as Chief Investor Relations and Communications Officer. Additionally, as previously announced, Max Reinhardt begins as President of the... Read More

LEWISVILLE, Texas / May 23, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Max Reinhardt as President of the Global Spine business effective June 10, 2024. Reinhardt will serve on the Executive Leadership Team and be responsible... Read More

LEWISVILLE, Texas / May 16, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it has been selected as winner of the “Best Patient Experience Solution” award in the 8 th annual MedTech Breakthrough Awards program. MedTech Breakthrough is an... Read More

LEWISVILLE, Texas / May 09, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its Rodeo ™ Telescopic Nail. The Rodeo Telescopic Nail is an innovative device... Read More

Recent Highlights Net sales of $188.6 million, an increase of 7.7% on a reported basis and 7.5% on a constant currency basis over prior year Bone Growth Therapies net sales growth of 10%, marking five consecutive quarters with double-digit net sales increases U.S. Spine Fixation 1 net sales growth of 16%, driven by distribution expansion and further penetration in existing accounts Global Orthopedics net sales growth of 5%... Read More

LEWISVILLE, Texas / Apr 23, 2024 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its first quarter 2024 financial results on Tuesday, May 7, 2024 before market open. The Company will host a conference call and webcast to review results at 8:30 a.m. ET the same day. Interested parties may access the conference call by dialing (888)... Read More

LEWISVILLE, Texas / Apr 16, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Andres Cedron has joined the company as Chief Legal Officer. Cedron most recently served as Vice President and Corporate Secretary at Stryker Corporation, a $20B+ global... Read More

LEWISVILLE, Texas / Mar 18, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Lucas Vitale has joined the company in the newly created role of Chief People and Business Operations Officer. Vitale most recently served as the Chief Human Resources Officer (CHRO) at ReNAgade Therapeutics, a venture backed pharmaceutical company, and prior to that,... Read More

Recent Highlights Fourth quarter 2023 net sales of $200.4 million, an increase of 64% on a reported basis and 7% on a pro forma constant currency basis Bone Growth Therapies net sales growth of 15% for the fourth quarter of 2023, marking four consecutive quarters with double-digit net sales increases, representing the strongest quarter of Bone Growth Therapies sales in the history of Orthofix U.S. Orthopedic net sales growth... Read More

LEWISVILLE, Texas / Feb 29, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Jason Shallenberger to President of the Bone Growth Therapies business, and the realignment of its Spine business unit, effective March 1. A seasoned sales leader, Shallenberger previously served as Vice President of U.S. Sales and Marketing for the... Read More

LEWISVILLE, Texas / Feb 21, 2024 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its fourth quarter and full year 2023 financial results on Tuesday, March 5, 2024 after market close. The Company will host a conference call and webcast to review results at 4:30 p.m. ET the same day. Interested parties may access the conference call by... Read More

First radiation-free spine procedures using pre-operative MRI completed with the 7D FLASH Navigation System and BoneMRI Technology LEWISVILLE, TEXAS / Jan 18, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced it has entered into an agreement with... Read More

LEWISVILLE, Texas / Jan 16, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Julie Andrews has officially stepped into the role of Chief Financial Officer (CFO). A seasoned executive, Ms. Andrews previously served as CFO for Smart Wires Technology, a global transmission grid technology company focused on enabling the transition to renewable... Read More

Net sales of $200.3 million, an increase of 64% on a reported basis and an increase of 8% on a pro forma basis Bone Growth Therapies growth of 15%, marking four consecutive quarters with double-digit net sales increases, and representing the strongest quarter of Bone Growth Therapies sales in the history of Orthofix U.S. Spinal Implants, Biologics, and Enabling Technologies growth of 4% on a pro forma basis over Q4 2022... Read More

Massimo Calafiore begins as President and Chief Executive Officer, effective immediately Julie Andrews is appointed as Chief Financial Officer, assuming the role effective January 15, 2024 LEWISVILLE, Texas / Jan 08, 2024 / Business Wire / Orthofix Medical Inc . (NASDAQ: OFIX), a leading global spine and orthopedics company, today announced that effective immediately, Massimo Calafiore has assumed the role of President and... Read More

LEWISVILLE, Texas / Dec 21, 2023 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the publication of new data from a prospective, multicenter study investigating Pulsed Electromagnetic Field (PEMF) stimulation as an adjunct therapy to lumbar spinal fusion... Read More

Three New Directors Bring Substantial Finance, Strategic Development, Healthcare and MedTech Experience LEWISVILLE, Texas / Dec 12, 2023 / Business Wire / Orthofix Medical Inc. (NASDAQ: OFIX) (“Orthofix” or the “Company”) today announced the appointment of three new independent directors to the Company’s Board. These new directors bring substantial finance, strategic development, healthcare and medical technology experience... Read More

With more than 100,000 implantations worldwide, the M6-C and M6-L discs continue to demonstrate strong clinical performance, safety and patient benefits LEWISVILLE, Texas / Nov 29, 2023 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the publication of the... Read More

Value-Building Medical Device Executive with 20-Year Record of Driving Market-Leading Growth Across Orthopedics and Spine Businesses Global Leader with Extensive M&A Integration Expertise and Commercial and Operating Experience Across Key Orthofix Geographies LEWISVILLE, Texas / Nov 28, 2023 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, announced today that Massimo... Read More

In November 2023, entered into a new four-year financing agreement with borrowing capacity of up to $150 million Net sales of $184.0 million, an increase of 61% on a reported basis and an increase of 8% on a pro forma basis when normalizing for a one-time stocking order that occurred in the third quarter of 2022 for SeaSpine Bone Growth Therapies growth of 15%, marking three consecutive quarters with double-digit net sales... Read More

LEWISVILLE, Texas / Nov 06, 2023 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full U.S. commercial launch of the WaveForm ® L Lateral Lumbar Interbody System. Designed for lateral lumbar interbody fusion (LLIF) procedures, the 3D-printed WaveForm L... Read More

LEWISVILLE, Texas / Oct 18, 2023 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its third quarter 2023 financial results on Wednesday, November 8, 2023 after market close. The Company will host a conference call and webcast to review results at 4:30 p.m. ET the same day. Interested parties may access the conference call by dialing... Read More

LEWISVILLE, Texas / Oct 12, 2023 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the 510k clearance and full commercial launch of OsteoCove ™ , an advanced bioactive synthetic graft. Available in both a putty and strip configuration, OsteoCove was carefully... Read More

LEWISVILLE, Texas / Sep 20, 2023 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full U.S. commercial launch and successful completion of the first cases with the Galaxy Fixation Gemini ™ system. The latest in the Galaxy product line, this stable... Read More

Catherine Burzik Appointed Interim Chief Executive Officer Geoffrey Gillespie Appointed Interim Chief Financial Officer Puja Leekha Appointed Interim Chief Legal Officer LEWISVILLE, Texas / Sep 12, 2023 / Business Wire / Orthofix Medical Inc. (NASDAQ: OFIX), a leading global spine and orthopedics company, today announced that Catherine Burzik, Chair of the Orthofix Board of Directors, has been appointed Interim Chief... Read More

LEWISVILLE, Texas / Aug 31, 2023 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the Company will participate in the Morgan Stanley Healthcare Conference in New York City. Management is scheduled to present on Tuesday, September 13, 2023 at 1:35 p.m. ET. Interested parties can access the live and archived webcast of the presentation on the Investors... Read More

LEWISVILLE, Texas / Aug 28, 2023 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full commercial launch and successful completion of the first cases in the U.S. with the 7D FLASH ™ Navigation System Percutaneous Module 2.0. The Percutaneous Module 2.0... Read More

LEWISVILLE, Texas / Aug 23, 2023 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the company will host an Investor Day at the Lewisville, TX headquarters on Wednesday, September 20, 2023 at 1:00pm Central Time. A live and archived webcast of the presentations will be available on the Investor’s page of the company’s website at ir.Orthofix.com.... Read More

Net sales of $187.0 million, an increase of 58% on a reported basis and 7% on a pro forma constant currency basis over prior year Bone Growth Therapies growth of 10%, marking two consecutive quarters with double-digit net sales increases, with growth coming from both spine and fracture commercial channels U.S. spinal implants, biologics, and enabling technologies sales up 7% over prior year on a pro forma basis, driven by... Read More

LEWISVILLE, Texas / Jul 25, 2023 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its second quarter 2023 financial results on Tuesday, August 8, 2023 after market close. The Company will host a conference call and webcast to review results at 4:30 p.m. ET the same day. Interested parties may access the conference call by dialing (888)... Read More

Celebrating 30 Years of Clinical Use, More Than 100,000 Patients Worldwide Have Benefited From TrueLok Circular Fixation Products LEWISVILLE, Texas / Jun 28, 2023 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the launch of the TrueLok ™ Phantom and... Read More

LEWISVILLE, Texas / Jun 20, 2023 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Catherine Burzik has been re-appointed as the Chair of the Company’s Board of Directors. Additionally, shareholders re-elected Wayne Burris who previously served on the Orthofix board from 2021-2022. Burris will serve on the Audit and Finance and Compliance and Ethics... Read More

LEWISVILLE, Texas / Jun 19, 2023 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full commercial launch of the WaveForm ® A interbody for Anterior Lumbar Interbody Fusion (ALIF) procedures. The WaveForm A interbody seamlessly integrates with the... Read More

LEWISVILLE, Texas / Jun 01, 2023 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the presentation of multiple clinical and scientific abstracts during the International Society for the Advancement of Spine Surgery (ISASS) annual meeting in San Francisco... Read More

Net sales of $175.2 million, an increase of 65% on a reported basis and 12% on a pro forma constant currency basis over prior year Bone Growth Therapies growth of 14%, with growth coming from both spine and fracture commercial channels U.S. spinal implant sales up 18% over prior year on a pro forma basis, driven by new distribution and product innovation Continued double-digit growth in Global Orthopedics over prior year on... Read More

LEWISVILLE, Texas / May 04, 2023 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the STIM onTrack ™ mobile app was recognized as the “Best Patient Engagement Mobile App” by MedTech Breakthrough, an independent market intelligence organization that... Read More

LEWISVILLE, Texas / Apr 26, 2023 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its first quarter 2023 financial results on Tuesday, May 9, 2023 after market close. The company will host a conference call and webcast to review results at 4:30 p.m. ET the same day. Interested parties may access the conference call by dialing (888)... Read More

LEWISVILLE, Texas / Apr 25, 2023 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full commercial launch of two access retractor systems to aid surgeons during minimally invasive spine (MIS) procedures. The Lattus ™ Lateral Access System and the Fathom... Read More

LEWISVILLE, Texas / Mar 06, 2023 / Business Wire / The merger of Orthofix Medical Inc. (NASDAQ:OFIX) ("Orthofix") and SeaSpine Holdings Corporation ("SeaSpine") became effective as of January 5, 2023. This news release includes the financial results of stand-alone Orthofix and stand-alone SeaSpine for the fourth quarter and full year ended December 31, 2022. As such, these financial results do not include any potential... Read More

LEWISVILLE, Texas / Mar 03, 2023 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will host an Analyst Teach-In Meeting in Lewisville, TX on Monday, March 13, 2023 from 2:30 - approximately 6:30 p.m. CT. The event will feature presentations from the C-Suite management team and business unit leaders describing the product portfolio of the newly... Read More

LEWISVILLE, Texas / Feb 21, 2023 / Business Wire / Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its fourth quarter 2022 financial results of stand-alone Orthofix as well as stand-alone SeaSpine, which was merged into Orthofix effective January 5, 2023, on Monday, March 6, 2023 after market close. The company will host a conference call and webcast... Read More

LEWISVILLE, Texas / Jan 26, 2023 / Business Wire / Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the full commercial launch of, and first patient cases involving, the Mariner ® Deformity Pedicle Screw System. The first product launched since the merger of Orthofix and... Read More

(NASDAQ:OFIX) The merger of equals between Orthofix Medical Inc. ("Orthofix") and SeaSpine Holdings Corporation ("SeaSpine") became effective as of January 5, 2023. This news release includes the pre-merger unaudited preliminary net sales results of stand-alone SeaSpine and stand-alone Orthofix for the fourth quarter and full year ended December 31, 2022. As such, these preliminary financial results do not include any... Read More

Orthofix and SeaSpine Stockholders Approve Merger Orthofix Medical Inc. ( NASDAQ: OFIX) and SeaSpine Holdings Corporation today announced the successful completion of their previously announced merger of equals following the approval of each company’s stockholders at respective special meetings of stockholders held today. Of votes cast, 99% of SeaSpine common shares were voted in approval of the merger, and 98% of Orthofix... Read More

Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced results from a prospective, multicenter clinical study evaluating the safety and efficacy of the Trinity Elite ™ cellular bone allograft (CBA) in lumbar spinal fusion procedures. Published in Neurology... Read More